About CRA | Expertise | Consultants | Publications | News | Events | Offices | Careers                                                                         
Take a closer look. The European Commission launched a sector inquiry into the pharmaceutical
industry, targeting allegations that generic entry was delayed and innovation had declined. On behalf
of EFPIA, the branded manufacturers' trade association, CRA responded with two reports discussing
competition and innovation in pharmaceutical markets.